|
Alieva A.M., Pinchuk T.V., Batov M.A., Voronkova K.V., Valiev R.K., Shnakhova L.M., Kalova M.R., Rakhaev A.M., Arakelyan R.A., Nikitin I.G.
Sindecan-1 and cardiovascular diseases
|
№8 / 2021
|
|
Naumov A.V., Prokofieva T.V., Polunina O.S., Saroyants L.V., Lipnitskaya E.A., Polunina E.A.
Levels of apoptosis indicators in patients with myocardial infarction on the background of chronic obstructive pulmonary disease depending on the time of development of myocardial ischemia
|
№6 / 2021
|
|
Kostrova O.Yu., Stomenskaya I.S., Timofeeva N.Yu., Struchko G.Yu., Bubnova N.V., Chesnokova A.E., Samushkina A.V.
Troponin I and D-dimer in diagnostics of myocardial infarction
|
№7 / 2019
|
|
Mazurov V.I., Petrova M.S., Gaydukova I.Z., Inamova O.V., Fonturenko A.Yu., Gaydukova E.K., Shapovalov A.A., Nagirnyak I.M.
Features of gouty arthritis according to the St. Petersburg City register of gout (2016–2018 years)
|
№6 / 2019
|
|
Grigorieva A.Yu., Amineva N.V., Asoskova A.V.
Difficulties in diagnostics and treatment of recurrent pulmonary embolism in comorbid pathology: a case from practice
|
№4 / 2019
|
|
Seliverstova D.V., Yakushin S.C., Kalinina L.P., Aksent’ev S.B.
Сlinical characteristics of myocardial infarction of women with preserved menstrual function
|
№1 / 2019
|
|
A.N. Meshkov
Evolocumab – a new medicine for hypercholesterinemia treatment
|
№6 / 2017
|
|
A.M. Nazarov, R.I. Sayfutdinov, O.V. Bugrova
Priorities of health survey at patients with angina pectoris
|
№4 / 2017
|
|
D.V. Odintsova, A.G. Malyavin, O.V. Zairatyants
The complexity of the diagnosis of pneumonia in patients with acute vascular events
|
№1 / 2017
|
|
A.L. Khokhlov, Yu.V. Rybachkova
Antagonists of mineralocorticoid receptors in myocardial infarction: focus on eplerenone
|
№4 / 2016
|
|
I.G. Gordeev, Ye.O. Taratukhin, Ye.T. Razumova
Eplerenone in myocardial infarction
|
№3 / 2016
|
Русский
